First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...

The California Institute for Regenerative Medicine (CIRM) has awarded $9 million to Loma Linda University Health  to create a Community Care Center of Excellence (CCCE) in the Inland Empire and Desert ...

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ... Conference call and webcast scheduled for today at ...

Three owners of Toyota’s Mirai hydrogen-fuel-cell vehicle have filed a class-action lawsuit against the Japanese manufacturer ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...

Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...

Good morning, and welcome to the SELLAS Life Sciences R&D Day. As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the ...

Wolters Kluwer Legal & Regulatory's ELM Solutions business will gather industry leaders in celebration of Amplify 2025, the business' award-winning user conference. Clients will have the opportunity ...

Buying Japanese also locks Japan even more closely into US-led alliances in the Asia-Pacific region. Japan is already part of ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

Following the adoption of 'a motion of urgent public importance' moved by Hon Amobi Ogah, the House of Representatives resolved last week to investigate the '$460 million' Chinese loan secured by the ...